Travelers’ diarrhea in children: risk factors, clinical features, and therapeutic recommendations
- Autores: Alagova M.V.1, Ratnikov V.A.1,2, Razdyakonova I.V.1, Ermolenko K.D.1,2, Silav K.V.1,3, Ratnikova A.K.4
-
Afiliações:
- Federal Scientific and Clinical Center for Infectious Diseases, Federal Medical and Biological Agency
- St. Petersburg State University
- S.P. Botkin Clinical Infectious Diseases Hospital
- L.G. Sokolov North-West District Scientific and Clinical Center, Federal Medical and Biological Agency
- Edição: Volume 32, Nº S (2025)
- Páginas: 50-56
- Seção: Original articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/687878
- DOI: https://doi.org/10.18565/pharmateca.2025.1-s1.50-56
- ID: 687878
Citar
Texto integral



Resumo
Background: Travelers’ diarrhea (TD) is one of the most common forms of infectious diarrhea. Despite the fact that the problem of TD in children has attracted the attention of infectious disease specialists and pediatricians for several decades, ideas about the epidemiology, clinical and laboratory features of the course and tactics of prehospital and inpatient treatment require further clarification.
Objective: Identification of the nosological structure, features of the clinical course, the effectiveness of the therapy used in children with travelers’ diarrhea (TD).
Materials and methods: The retrospective, non-randomized, two-center study was conducted. The study randomly included 394 patients treated in the period 2021-2024 with travelers’ diarrhea. The data of the epidemiological history, clinical follow-up of patients, laboratory examination were evaluated, and a clinical and laboratory comparison of the effectiveness of nifuroxazide for TD was carried out.
Results: A significant role of both viral and bacterial pathogens in the development of diarrhea in children was shown, as well as frequent detection of excessive growth of opportunistic microorganisms in this pathology, as well as the positive effects of taking nifuroxazide in early empirical therapy and in a 24-hour hospital settings.
Palavras-chave
Texto integral

Sobre autores
Milana Alagova
Federal Scientific and Clinical Center for Infectious Diseases, Federal Medical and Biological Agency
Email: milana.alagova@yandex.ru
ORCID ID: 0009-0002-8967-2059
full-time postgraduate student
Rússia, St. PetersburgVyacheslav Ratnikov
Federal Scientific and Clinical Center for Infectious Diseases, Federal Medical and Biological Agency; St. Petersburg State University
Email: dr.ratnikov@mail.ru
ORCID ID: 0000-0002-9645-8408
Dr. Sci. (Med.), Professor, Acting Director General, Federal Scientific and Clinical Center for Infectious Diseases, Professor, Department of Radiation Diagnostics
Rússia, St. Petersburg; St. PetersburgIrina Razdyakonova
Federal Scientific and Clinical Center for Infectious Diseases, Federal Medical and Biological Agency
Email: ermolenko.kd@yandex.ru
Cand. Sci. (Med.), Head of the Department of Intestinal Infections
Rússia, St. PetersburgKonstantin Ermolenko
Federal Scientific and Clinical Center for Infectious Diseases, Federal Medical and Biological Agency; St. Petersburg State University
Autor responsável pela correspondência
Email: ermolenko.kd@yandex.ru
ORCID ID: 0000-0003-3643-7354
Dr. Sci. (Med.), Head of the Research Institute of Intestinal Infections, Associate Professor, Department of Infectious Diseases
Rússia, St. Petersburg; St. PetersburgKsenia Silav
Federal Scientific and Clinical Center for Infectious Diseases, Federal Medical and Biological Agency; S.P. Botkin Clinical Infectious Diseases Hospital
Email: ermolenko.kd@yandex.ru
ORCID ID: 0009-0008-0264-9504
postgraduate student, Research Department of Intestinal Infections, Physician
Rússia, St. Petersburg; St. PetersburgAnna Ratnikova
L.G. Sokolov North-West District Scientific and Clinical Center, Federal Medical and Biological Agency
Email: ermolenko.kd@yandex.ru
ORCID ID: 0000-0003-3279-6448
Cand. Sci. (Med.) Senior Researcher
Rússia, St. PetersburgBibliografia
- Захаренко С.М. Антибиотики и пробиотики в профилактике и терапии диареи путешественников. Инфекционные болезни. 2012;10(2):61–69. [Zakharchenko S.M. Antibiotics and probiotics in the prevention and treatment of traveler’s diarrhea. Infectious diseases. 2012;10(2):61–69. (In Russ.)].
- Бехтерева М.К., Луппова Н.Е., Приворотский В.Ф. Диареи путешественников у взрослых и детей. Вопросы практической педиатрии. 2014;9(2):48–58. [Bekhtereva M.K., Luppova N.E., Privorotsky V.F. Traveler’s diarrhea in adults and children. Voprosy prakticheskoy pediatrii. 2014;9(2):48–58. (In Russ.)].
- Страчкова Н., Страчкова З. Современные особенности развития мирового туристского рынка. Ученые записки Крымского федерального университета имени В.И. Вернадского. География. Геология. 2021;7(1):88–98. [Strachkova N., Strachkova Z. Modern features of the development of the world tourism market. Uchenyye zapiski Krymskogo federal’nogo universiteta imeni V.I. Vernadskogo. Geografiya. Geologiya. 2021;7(1):88–98. (In Russ.)].
- Симонян Г.А., Сарян А.А. Особенности формирования туристских потоков в современных условиях. Современная научная мысль. 2021;2:181–189. [Simonyan G.A., Saryan A.A. Features of the formation of tourist flows in modern conditions. Sovremennaya nauchnaya mysl’. 2021;2:181–189. (In Russ.)].
- Шептулин А.А., Кардашева С.С., Курбатова А.А. Особенности этиологии, клинической картины, диагностики и лечения диареи путешественников. Клиническая медицина. 2023;101(2-3):137–140. [Sheptulin A.A., Kardasheva S.S., Kurbatova A.A. Features of the etiology, clinical picture, diagnosis and treatment of traveler’s diarrhea. Klinicheskaya meditsina. 2023;101(2-3):137–140. (In Russ.)].
- Leung A.K., Leung A.A., Wong A.H., Hon K.L. Travelers’ diarrhea: a clinical review. Recent patents on inflammation & allergy drug discovery. 2019;13(1):38–48.
- Steffen R., Hill D.R., DuPont H.L. Traveler’s diarrhea: a clinical review. JAMA. 2015;313(1):71–80.
- Steffen R. Epidemiology of travellers’ diarrhea. Journal of travel medicine. 2017; 24(suppl_1):S2–S5.
- Riddle M.S., Connor B.A., Beeching N.J., et al. Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report. Journal of travel medicine. 2017;24(suppl_1):S63–S80.
- Porter C.K., Olson S., Hall A., Riddle M.S. Travelers’ diarrhea: an update on the incidence, etiology, and risk in military deployments and similar travel populations. Military medicine. 2017;182(suppl_2):4–10.
- Макарова М. Современное представление о диареегенных Escherichia coli–возбудителя острых кишечных инфекций. Журнал микробиологии, эпидемиологии и иммунобиологии. 2023;100(4):333–344. [Makarova M. Modern understanding of diarrheagenic Escherichia coli – the causative agent of acute intestinal infections. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 2023;100(4):333–344. (In Russ.)].
- Carroll S. C., Castellanos M. E., Stevenson R. A., Henning L. Incidence and risk factors for travellers’ diarrhoea among short-term international adult travellers from high-income countries: a systematic review with meta-analysis of cohort studies. Journal of Travel Medicine. 2025;32(2): taae008.
- Ермоленко К.Д., Комарова А.М., Драп А.С., Раздьяконова И.В. Диарея путешественников у детей. Фарматека. 2016;11:88–94. [Ermolenko K.D., Komarova A.M., Drap A.S., Razdyakonova I.V. Traveler’s diarrhea in children. Farmateka. 2016;11:88–94. (In Russ.)].
- Кучко А., Ефремова И., Федосеева И. Безопасность применения хинолонов и фторхинолонов. Рецепт. 2023;26(3):339–349. [Kuchko A., Efremova I., Fedoseeva I. Safety of quinolones and fluoroquinolones. Retsept. 2023; 26(3):339–349.
- Ермоленко К., Гончар Н. Возможности профилактики и медикаментозной терапии гастроэнтерологической патологии после вирусных кишечных инфекций у детей. Фарматека. 2020;27(9):86–91. [Ermolenko K.D., Gonchar N.V. Possibilities of prevention and drug therapy of gastroenterological pathology after viral intestinal infections in children. Farmateka. 2020;27(9):86–91. (In Russ.)]. DOI: https://dx.doi.org/10.18565/pharmateca.2020.9.86-91
- Бельмер С. В., Гасилина Т. В. Дифференциальная диагностика и общие принципы терапии хронической диареи у детей. Фарматека. 2011;1:54–58. [Belmer S.V., Gasilina T.V. Differential Diagnosis And General Principles Of Therapy Of Chronic Diarrhea In Children. Farmateka. 2011;1:54–58. (In Russ.)].
Arquivos suplementares
